Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.
BACKGROUND:The combination of short-acting dihydroartemisinin and long-acting piperaquine (DP) is among the first-line therapies for the treatment of uncomplicated Plasmodium falciparum malaria. Population pharmacokinetic models of piperaquine (PQ) based on data from acute treatment of young childre...
Main Authors: | Nancy C Sambol, Jordan W Tappero, Emmanuel Arinaitwe, Sunil Parikh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4868321?pdf=render |
Similar Items
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Palang Chotsiri, et al.
Published: (2019-01-01) -
Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine
by: Bergstrand, M., et al.
Published: (2017) -
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
by: Kamya Moses, et al.
Published: (2009-01-01) -
Analysis of dose regimens efficacy of Dihydroartemisine-piperaquine in adults and children suffering from acute malaria in Cameroon
by: A. L. Same Ekobo, et al.
Published: (2014-04-01) -
Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
by: Issaka Zongo, et al.
Published: (2014-01-01)